3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Neoplasm Metastasis
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Gliosarcoma
2
Glioblastoma
2
Uterine Cervical Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoblastic Lymphadenopathy
1
Glioma
1
Enteropathy-Associated T-Cell Lymphoma
1
Brain Neoplasms
1
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Automobiles
×
Clear all
No trials found.